Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 13 | 0 | 0 | 13 |
ATAD5 protein, partial | 7 | 0 | 0 | 7 |
GLS protein | 11 | 0 | 0 | 11 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
Smad3 | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
progesterone receptor | 13 | 0 | 0 | 13 |
EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
retinoic acid nuclear receptor alpha variant 1 | 15 | 0 | 0 | 15 |
retinoid X nuclear receptor alpha | 14 | 0 | 0 | 14 |
estrogen-related nuclear receptor alpha | 17 | 0 | 0 | 17 |
estrogen nuclear receptor alpha | 27 | 0 | 0 | 27 |
peroxisome proliferator activated receptor gamma | 11 | 0 | 0 | 11 |
aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 3 | 1 | 11 |
ATP-binding cassette sub-family C member 3 | 0 | 17 | 0 | 17 |
Multidrug resistance-associated protein 4 | 0 | 17 | 0 | 18 |
Solute carrier family 22 member 6 | 0 | 7 | 0 | 7 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
Bile salt export pump | 0 | 26 | 0 | 26 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 10 | 0 | 11 |
Carbonic anhydrase 2 | 0 | 10 | 0 | 11 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 11 | 0 | 12 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 6 | 1 | 7 |
Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
Cytochrome P450 2C9 | 0 | 12 | 0 | 13 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 3 | 1 | 11 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 3 | 1 | 11 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 4 |
Glutamate receptor 2 | 6 | 2 | 2 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 3 | 1 | 11 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 13 | 0 | 13 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 3 | 1 | 11 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 11 | 1 | 13 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
Cytochrome P450 2J2 | 0 | 10 | 0 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 4 | 1 | 12 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 3 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 3 | 1 | 11 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
GABA theta subunit | 7 | 3 | 1 | 11 |
Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 17 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 3 | 1 | 11 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 11 | 0 | 0 | 11 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 8 | 0 | 0 | 8 |
Chain B, HADH2 protein | 8 | 0 | 0 | 8 |
Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 2 | 0 | 0 | 2 |
thioredoxin reductase | 10 | 0 | 0 | 10 |
AR protein | 24 | 0 | 0 | 24 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 8 | 0 | 0 | 8 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 19 | 0 | 0 | 19 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, liver | 0 | 6 | 0 | 6 |
Integrin beta-3 | 0 | 1 | 1 | 2 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 0 | 1 | 1 | 2 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 4 | 0 | 4 |
Adenosine receptor A2a | 0 | 4 | 0 | 4 |
Substance-P receptor | 0 | 4 | 0 | 4 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
pregnane X receptor | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 14 | 0 | 0 | 14 |
farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 13 | 0 | 0 | 13 |
nuclear receptor subfamily 1, group I, member 2 | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 15 | 0 | 0 | 15 |
Glucocorticoid receptor | 0 | 14 | 2 | 21 |
Glycine receptor subunit alpha-1 | 0 | 14 | 0 | 14 |
Glycine receptor subunit beta | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-2 | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-3 | 0 | 14 | 0 | 14 |
ORF73 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
TDP1 protein | 19 | 0 | 0 | 19 |
estrogen receptor 2 (ER beta) | 7 | 0 | 0 | 7 |
67.9K protein | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 3 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 3 | 1 | 5 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Cannabinoid receptor 2 | 0 | 3 | 1 | 5 |
Spike glycoprotein | 6 | 0 | 0 | 6 |
D(2) dopamine receptor | 0 | 0 | 2 | 2 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 0 | 1 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 3 | 1 | 5 |
Dipeptidase 1 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 10 | 0 | 11 |
Solute carrier family 22 member 8 | 0 | 5 | 0 | 6 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 5 | 0 | 0 | 5 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 6 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 7 | 0 | 0 | 7 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
geminin | 15 | 0 | 0 | 15 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 2 |
Dihydrofolate reductase | 0 | 4 | 0 | 4 |
Cytochrome c oxidase subunit 2 | 0 | 2 | 0 | 2 |
Transthyretin | 0 | 1 | 3 | 8 |
Albumin | 0 | 7 | 5 | 12 |
Interleukin-8 | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 4 | 1 | 5 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 5 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 7 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 8 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Luciferase | 11 | 0 | 0 | 11 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
SMAD family member 2 | 9 | 0 | 0 | 9 |
SMAD family member 3 | 9 | 0 | 0 | 9 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 9 | 0 | 0 | 9 |
G | 9 | 0 | 0 | 9 |
activating transcription factor 6 | 5 | 0 | 0 | 5 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
Interferon beta | 13 | 0 | 0 | 13 |
HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
Cellular tumor antigen p53 | 12 | 0 | 0 | 12 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 2 | 2 | 4 |
Glutamate receptor 3 | 0 | 2 | 2 | 4 |
Glutamate receptor 4 | 0 | 2 | 2 | 4 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
D(3) dopamine receptor | 0 | 2 | 1 | 3 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 1 | 2 |
N-arachidonyl glycine receptor | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Lysophosphatidylserine lipase ABHD12 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Monoglyceride lipase | 0 | 1 | 0 | 1 |
Ataxin-2 | 8 | 0 | 0 | 8 |
Monoacylglycerol lipase ABHD6 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
G-protein coupled receptor 55 | 0 | 1 | 1 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
PPM1D protein | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
caspase-3 | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C4 | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member C3 | 0 | 5 | 0 | 5 |
Aldo-keto reductase family 1 member C2 | 0 | 3 | 0 | 3 |
Acid-sensing ion channel 1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 3 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 2 | 6 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 2 | 6 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 2 | 6 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 2 | 6 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 2 | 6 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 2 | 6 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 2 | 6 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 4 | 0 | 0 | 4 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 3 | 2 | 6 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 4 |
Alpha-2C adrenergic receptor | 0 | 3 | 2 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
Nischarin | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
snurportin-1 | 4 | 0 | 0 | 4 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
arylsulfatase A | 6 | 0 | 0 | 6 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 8 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Caspase-1 | 0 | 3 | 0 | 4 |
Caspase-3 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 3 | 0 | 3 |
Caspase-5 | 0 | 3 | 0 | 3 |
Caspase-9 | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Beta-lactamase TEM | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Androgen receptor | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
Androgen receptor | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 1 | 4 |
Delta-type opioid receptor | 0 | 2 | 2 | 4 |
Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 3 | 2 | 5 |
Kappa-type opioid receptor | 0 | 1 | 2 | 3 |
Mu-type opioid receptor | 0 | 3 | 2 | 6 |
Delta-type opioid receptor | 0 | 3 | 2 | 6 |
Kappa-type opioid receptor | 0 | 3 | 3 | 7 |
Mu-type opioid receptor | 0 | 1 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 4 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
Neuromedin-K receptor | 0 | 0 | 2 | 2 |
Substance-K receptor | 0 | 1 | 2 | 3 |
Substance-K receptor | 0 | 4 | 0 | 5 |
Substance-P receptor | 0 | 3 | 1 | 4 |
Neuromedin-K receptor | 0 | 2 | 2 | 4 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 2 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 1 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Geranylgeranyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 1 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
D(2) dopamine receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 4 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1D adrenergic receptor | 0 | 0 | 1 | 2 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |